LC/MS를 이용한 물 환경내의 잔류의약품 분석
Analysis of Pharmaceutical Residues on Aquatic Environment using LC/MS
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Recent concerns on environmental impacts of pharmaceutical residues lead to many occurrence surveys in several important media. However most of such investigations have been conducted in North America and Europe, and rarely carried out in Asian region. We collected influent and effluent samples from four sewage treatment plants as well as upstream and downstream surface water samples in Han River of Seoul, Korea, in three events, i.e., April, June, and August, 2005, and analyzed for eleven frequently used pharmaceuticals using LC-MS-ESI. Levels of pharmaceutical residues in wastewater influents were the highest for acetaminophen (average 27,089 ng/L), followed by caffeine (23,664 ng/L), cimetidine (8,045 ng/L), and sulfamethoxazole (523 ng/L). Pharmaceuticals of high annual production amount were detected in higher level in STP influents. Removal effectiveness of STPs varied by the type of pharmaceuticals: Removal rates for acetaminophen and caffeine were near 100%, while for cimetidine, less than a third was removed by the sewage treatment process, which is activated sludge method. In STP effluents, cimetidine showed the highest level of occurrence (5,380 ng/L), followed by caffeine (278 ng/L), sulfamethoxazole (193 ng/L), and carbamazepine (111 ng/L). The concentration of cimetidine was also the highest in surface water (average 281 ng/L). Caffeine 268.7 ng/L), acetaminophen (34.8 ng/L), and sulfamethoxazole (26.9 ng/L) were also occurring in high levels. The hazard quotients were calculated for the test pharmaceuticals based on their occurrences in surface water, and no pharmaceutical resulted in HQ greater than one, suggesting that their tendency for potential environmental impact may be low.
Abstract
Recent concerns on environmental impacts of pharmaceutical residues lead to many occurrence surveys in several important media. However most of such investigations have been conducted in North America and Europe, and rarely carried out in Asian region. We collected influent and effluent samples from four sewage treatment plants as well as upstream and downstream surface water samples in Han River of Seoul, Korea, in three events, i.e., April, June, and August, 2005, and analyzed for eleven frequently used pharmaceuticals using LC-MS-ESI. Levels of pharmaceutical residues in wastewater influents were the highest for acetaminophen (average 27,089 ng/L), followed by caffeine (23,664 ng/L), cimetidine (8,045 ng/L), and sulfamethoxazole (523 ng/L). Pharmaceuticals of high annual production amount were detected in higher level in STP influents. Removal effectiveness of STPs varied by the type of pharmaceuticals: Removal rates for acetaminophen and caffeine were near 100%, while for cimetidine, less than a third was removed by the sewage treatment process, which is activated sludge method. In STP effluents, cimetidine showed the highest level of occurrence (5,380 ng/L), followed by caffeine (278 ng/L), sulfamethoxazole (193 ng/L), and carbamazepine (111 ng/L). The concentration of cimetidine was also the highest in surface water (average 281 ng/L). Caffeine 268.7 ng/L), acetaminophen (34.8 ng/L), and sulfamethoxazole (26.9 ng/L) were also occurring in high levels. The hazard quotients were calculated for the test pharmaceuticals based on their occurrences in surface water, and no pharmaceutical resulted in HQ greater than one, suggesting that their tendency for potential environmental impact may be low.
참고문헌 (16)
- A.B.A. Boxall, , Environ.mental Science and Technology, 37, pp.286~294 (2003)
- T. Herberer, , Toxicology Letters, 131, pp.5~17 (2002)
- D. Kolpin, , Environ. mental Science and Technology, 36, pp.1202~1211 (2002)
- E. L. Michele, "73 4640-4646", Anal. Chem, 73, pp.4640~4646 (2001)
- M. Bunker, , Am. Diet. Assoc, 74, pp.28~32 (1979)
- R. Piero, , Environment International, 28, pp.521~528 (2002)
- D. Tang-Liu, "24,180-195", J. Pharmacol Exp. Ther, 24, pp.180~195 (1983)
- Z. Ettore, , Journal of Hazardous Materials, 122, pp.205~209 (2005)
- C. Metcalfe, "Pharmaceuticals in the Environment", pp.45~53 (2004), Springer Second edition.
- 한국학술진흥재단, "KRF-2004-042-D00112", ~ (2005)
- A. Thomas, , 20, pp.419~434 (2001)
- X. Miao, , Environ Sci Technol
- G. Terry, "Occurrence of Anibiotics" (2007), Pharmaceuticals and Sterols at Select Surface and Wastewater Sites in Iowa
- A. Thomas, , Water Research, 37, pp.1976~1982 (2003)
- A. Garrison, , Ann Arbor Science, pp.517~566 (1976)
- C. Hignite, , Life Sciences, 20, pp.337~342 (1977)